Furthermore, PDGF-CC has been shown to increase the permeability of the blood–brain barrier (BBB) [27], and the role of the PDGFRα/PDGF-CC pathway relative to BBB dysfunction in neurological disorders was recently reviewed [28]. The gene discussed is CXCR1; the disease is nervous system disorder.